Home / Private raises / Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

Biotechnology · Kelowna, British Columbia, Canada · $113K sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-09-21D (new)$113K$113K3506(b)Options/warrantsSep 9SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Sold through (placement agents)

Broker-dealerSolicited in
H.C. WAINWRIGHT & CO.—

Sales commissions $8K in the latest filing.

Issuer

IndustryBiotechnology
LocatedKelowna, British Columbia, Canada
EntityCorporation
IncorporatedNevada
Revenue range$5,000,001 - $25,000,000
SEC CIK1348362

People named in the latest filing

NameRole
Christopher BunkaDirector
John DochertyExecutive Officer, Director
Richard ChristopherExecutive Officer, Director
Michael ShankmanExecutive Officer
Nicholas BaxterDirector
William Edward McKechnieDirector
ALBERT REESEDirector
Bal BhullarDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?